Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2019-05-10 Report Publication Anno…
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Notice of Results
Report Publication Announcement Classification · 1% confidence The document is a short announcement (2637 characters) disseminated via RNS (Regulatory News Service) from IXICO plc. The core content is the 'Notice of Results,' specifically stating that the company 'will announce its interim results for the six months ended 31 March 2019 on Wednesday, 22 May 2019.' This is not the interim report itself (which would be classified as IR), but rather an announcement about the future publication date of that report, including details about a subsequent analyst briefing. According to Rule 2, when a document is short and announces the publication of another report, it should be classified as a Report Publication Announcement (RPA).
2019-05-10 English
Update for first half of year ending 31 March 2019
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and contains key phrases like 'Trading update for the first half of financial year ending 31 March 2019', 'Reported revenues expected to be £3.43m for 6 months to 31 March 2019', and 'The Company's first half results will be released on 22 May 2019.' This structure—providing preliminary financial highlights for a specific interim period (six months) and announcing the date of the full results—is characteristic of an Earnings Release (ER). It is not the full Interim Report (IR) itself, but the initial announcement of the results. Since it provides key financial highlights before the full report release, ER is the most appropriate classification.
2019-04-25 English
Announces two new biopharmaceutical contracts
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content describes the signing of new commercial contracts for specialized services ('IXICO announces two new biopharmaceutical contracts'). This type of announcement, detailing business developments, contract wins, or operational updates that are material to investors but do not fit specific financial reporting categories (like 10-K, ER, or DIV), is typically classified as a general regulatory filing or news service release. Since the document is a direct announcement of business news and is explicitly marked as being provided by RNS, the most appropriate classification is 'Regulatory Filings' (RNS). It is not a formal financial report (like 10-K or IR) nor a specific corporate action announcement (like DIV or CAP).
2019-04-24 English
Change of Adviser
Regulatory Filings Classification · 1% confidence The document is very short (2455 characters) and is explicitly marked with an 'RNS Number'. The content announces a 'Change of Nominated Adviser & Sole Broker' for IXICO plc, effective immediately. This type of announcement, which is a specific corporate action update distributed via the London Stock Exchange's news service (RNS), fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Change of Adviser'. It is not a full report (like 10-K or IR), nor is it a management change (MANG) or a director's dealing (DIRS). It is a standard regulatory news service announcement.
2019-04-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with "RNS Number : 3502T" and contains the standard format for a notification to the Financial Conduct Authority (FCA) regarding changes in major shareholdings, specifically using the "TR-1: Standard form for notification of major holdings". This form details the acquisition or disposal of voting rights by a significant shareholder (Invesco Ltd.). This type of mandatory disclosure falls under the category of reporting changes in significant ownership thresholds. The presence of the RNS header and the nature of the content strongly indicate a regulatory filing related to share ownership changes, which aligns best with the 'Major Shareholding Notification' code (MRQ). Although it is distributed via RNS, the specific content is a TR-1 form, making MRQ the most precise classification.
2019-03-19 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is a formal notification disseminated via 'RNS Number', which stands for Regulatory News Service, the news service of the London Stock Exchange. The content explicitly details a 'Director and PDMR share purchase' (Persons Discharging Managerial Responsibilities) involving the Non-Executive Chairman, Charles Spicer. This type of insider transaction disclosure falls directly under the category of Director's Dealing (DIRS). Although it is distributed via RNS, the specific subject matter is highly targeted, making DIRS the most appropriate classification over the general RNS fallback.
2019-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.